Predictors of hypomagnesemia with denosumab in patients with metastatic bone disease from solid malignancies: A single-institution retrospective study,
Role: PI,
LLU Dept. of Pharmacy Practice,
(11/2023)
Status: Approved
Assessment of Utilization Patterns of Novel Hormonal Therapy (NHT) Agents in Non-metastatic Prostate Cancer,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(12/2021)
Status: Approved
Daily Dosing of Acyclovir for Viral Infection Prophylaxis in Patients with Hematologic Malignancy,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(10/2020)
Status: Approved
Risk Factors of Hypomagnesemia in Patients with Bone Metastases from Solid Malignancies Treated with Zoledronic Acid: A Single-institution Retrospective Study,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(10/2024)
Status: Approved
Cost analysis of subcutaneous daratumumab compared to intravenous daratumumab in multiple myeloma patients: A retrospective chart review,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(11/2024)
Status: Approved